Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Square Brussels Convention Centre

Mar 12, 2024 9:00 AM - Mar 14, 2024 4:00 PM

Glass Entrance, Mont des Arts/Kunstberg, 1000 Brussels, Belgium

DIA Europe 2024

Closing Session

Session Chair(s)

Sara  Torgal, MPharm

Sara Torgal, MPharm

Senior Manager, Scientific Programs

DIA, Switzerland

A must-attend review of the Conference Insights and Outcomes by the Conference Topic Leads, followed by closing remarks from the SVP and Managing Director of DIA EMEAI.

Speaker(s)

Ania   Mitan

Ania Mitan

DIA, Switzerland

Senior Vice President & Managing Director, DIA EMEA and India

Álmath  Spooner, PhD

Take 5: Artificial Intelligence, Data Science & RWE

Álmath Spooner, PhD

Abbvie, Ireland

Head of Europe Regulatory Policy & Intelligence (RPI)

Marianne  Lunzer, DrMed

Take 5: Clinical Trials Development & Operations

Marianne Lunzer, DrMed

AGES, Austria

Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care

Matt  Popkin, PhD

Take 5: CMC & Product Quality

Matt Popkin, PhD

GSK, United Kingdom

Senior Director, CMC Excellence, Global Regulatory Affairs

Sara  Torgal, MPharm

Take 5: International Collaboration & Regional Updates

Sara Torgal, MPharm

DIA, Switzerland

Senior Manager, Scientific Programs

Tim  Chesworth

Take 5: Medical Devices & Combination Products

Tim Chesworth

AstraZeneca, United Kingdom

Senior Director Regulatory Affairs

James  Whitehead, MBA, MSc

Take 5: Pharmacovigilance & Safety

James Whitehead, MBA, MSc

AstraZeneca, United Kingdom

Senior Director, Device & Digital Safety

Claudia   Ferreira

Take 5: Professional Development

Claudia Ferreira

DIA, Switzerland

Scientific Programs Manager

Rodrigo  Palacios, MBA

Take 5: Regulatory Operations

Rodrigo Palacios, MBA

F. Hoffmann-La Roche, Switzerland

Executive Director, Technical Regulatory Policy

Emma  Du Four, MBA

Take 5: Regulatory Strategy & EU Pharmaceutical Policy

Emma Du Four, MBA

United Kingdom

Regulatory and R&D Policy Professional

James  Ryan, MSc

Take 5: Value and Access

James Ryan, MSc

AstraZeneca (Global), UK, United Kingdom

Director, Global HTA Policy

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.